Helen Sheridan
Corporate Officer/Principal en Irish Medicines Board .
Perfil
Helen Sheridan is the founder of Trino Therapeutics Ltd., which was founded in 1999.
She held the title of Principal Chemist & IP Specialist from 1999 to 2012.
Currently, she is a Member of the Irish Medicines Board.
Dr. Sheridan received a doctorate degree from University College Dublin.
Cargos activos de Helen Sheridan
Empresas | Cargo | Inicio |
---|---|---|
Irish Medicines Board | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Helen Sheridan.
Empresas | Cargo | Fin |
---|---|---|
Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Trino Therapeutics Ltd. operates as a drug discovery and development company. It focuses on developing oral small molecules for the treatment and unmet management of inflammatory bowel disease and other inflammatory indications. The company was founded by Neil Howard Frankish and Helen Sheridan in 1999 and is headquartered in Dublin, Ireland. | Fundador | - |
Formación de Helen Sheridan.
University College Dublin | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Trino Therapeutics Ltd. operates as a drug discovery and development company. It focuses on developing oral small molecules for the treatment and unmet management of inflammatory bowel disease and other inflammatory indications. The company was founded by Neil Howard Frankish and Helen Sheridan in 1999 and is headquartered in Dublin, Ireland. | Health Technology |
Irish Medicines Board |
- Bolsa de valores
- Insiders
- Helen Sheridan